Researchers believe their new findings may supersede the amyloid hypothesis of Alzheimer's disease.
Researchers have identified key molecular pathways which lead to late-onset Alzheimer's disease. The study presents a new approach to Alzheimer's research and highlights several potential drug targets.
Researchers have identified and validated two rare gene mutations which could be a cause for late onset Alzheimer's disease.
Researchers have developed a new rat model of Alzheimer's disease that can be used to study the accumulation of amyloid plaques.
Amyloid beta can be reduced when sugars are prevented from binding to a key enzyme associated with Alzheimer's disease, researchers report.
Researchers at UBC believe they have identified a method that could help stop Alzheimer's disease in its tracks.
An international research team revealed the atomic‐level structure of the human peptidase enzyme meprin β (beta).
Researchers identify compounds that stabilize retromer protein complex and protects neurons from amyloid-beta.
Researchers report older women living in areas with fine particulate matter exceeding the EPA's standard are at significantly higher risk of developing dementia.
Study identifies the main components driving amyloid beta-associated synaptic degeneration.
Researchers identified gene recombination in neurons that produces new gene variants in the brains of those with Alzheimer's disease. The findings, researchers say, may point to a potential near term treatment for the neurodegenerative disease.
Researchers have developed a new class of drugs that may be more precise at blocking the production of toxic forms of amyloid beta.
